rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2002-1-4
|
pubmed:abstractText |
Liver donors with serological evidence of resolved hepatitis B virus (HBV) infection (HBV surface antigen (HBsAg) negative, anti-HBV core (HBc) positive) can transmit HBV infection to recipients. In the context of organ shortage, we investigated the efficacy of hepatitis B immunoglobulin (HBIG) to prevent HBV infection, and assessed the infectious risk by polymerase chain reaction (PCR) testing for HBV DNA on serum and liver tissue of anti-HBc positive donors.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-10072408,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-10532552,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-10655275,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-10915164,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-11772957,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-2475766,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-7715341,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-7839446,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-7904004,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-8247035,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-8282792,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-8438221,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-8787682,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-9075658,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-9346638,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-9346723,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-9352871,
http://linkedlifedata.com/resource/pubmed/commentcorrection/11772974-9415560
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0017-5749
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
95-9
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:11772974-Antiviral Agents,
pubmed-meshheading:11772974-DNA, Viral,
pubmed-meshheading:11772974-Hepatitis B, Chronic,
pubmed-meshheading:11772974-Hepatitis B Core Antigens,
pubmed-meshheading:11772974-Hepatitis B Surface Antigens,
pubmed-meshheading:11772974-Hepatitis B virus,
pubmed-meshheading:11772974-Humans,
pubmed-meshheading:11772974-Immunoenzyme Techniques,
pubmed-meshheading:11772974-Immunoglobulins, Intravenous,
pubmed-meshheading:11772974-Lamivudine,
pubmed-meshheading:11772974-Liver Transplantation,
pubmed-meshheading:11772974-Polymerase Chain Reaction,
pubmed-meshheading:11772974-Treatment Outcome,
pubmed-meshheading:11772974-Virus Activation
|
pubmed:year |
2002
|
pubmed:articleTitle |
Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
|
pubmed:affiliation |
Laboratoire de Virologie, Hôpital Paul Brousse, Université Paris-Sud UPRES 1596, 12 avenue Paul Vaillant Couturier, 94804 Villejuif, France. anne-marie.roque@pbr-ap-hop-paris.fr
|
pubmed:publicationType |
Journal Article
|